Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3356 of 6351
-
New needle could offer better back pain relief
Symptom relief Recruiting nowThe purpose of this study is to better understand how people feel after a radiofrequency ablation standard of care surgery using a different type of needle (multi-tined expandable electrode/MEE) in comparison to receiving conventional medical management (CMM) techniques.
Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple test predict stomach cancer return?
Knowledge-focused Recruiting nowBecause advanced gastric cancer shows poor prognosis, it is important to detect early gastric cancer or precancerous gastric adenoma patients who have a cure rate of 95% or more. Moreover, a large part of early gastric cancer can be completely resected by endoscopic resection, th…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:55 UTC
-
Enzyme therapy aims to fight wasting in pancreatic cancer patients
Disease control OngoingThe objective of this study is to assess weight stability, functional changes, and quality of life when Pancreaze (pancrelipase) delayed-release 84,000-lipase units (capsules), for main meals, and 42,000-lipase units (capsules), for snacks, are added to standard of care in patien…
Phase 2 • Sponsor: Andrew Hendifar, MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
AI boosts polyp detection in colon cancer screening Follow-Up
Diagnosis CompletedThe goal of this clinical trial is to evaluate the diagnostic yield of CADe in a consecutive population undergoing colonoscopy. The main question it aims to answer is the Adenoma Detection Rate (ADR). Participants undergoing colonoscopy for follow-up in a screening setting will b…
Sponsor: Fondazione Poliambulanza Istituto Ospedaliero • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New therapy tackles PTSD and drinking after sexual assault
Symptom relief CompletedThis study is for women who have experienced a sexual assault in the past six weeks and use alcohol. The research involves completing a five week behavioral treatment for stress and alcohol use. Participants will complete surveys during visits. Participants may also be asked to c…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Ongoing* To evaluate the safety and tolerability of escalating doses of ERAS-601 when administered as a monotherapy and in combination with other cancer therapies in study participants with advanced or metastatic solid tumors. * To determine the Maximum Tolerated Dose (MTD) and/or recom…
Phase 1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Peer power: mentors help young diabetics navigate adult care
Disease control CompletedDiaBetter Together is a strengths-based peer support intervention delivered to young adults (age 17-25) by trained Peer Mentors (age 20-35) during the transition between pediatric and adult diabetes care. The aims of this proposed randomized controlled trial are to evaluate the i…
Phase 2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Web-Based insomnia treatment shows promise for childhood cancer survivors
Symptom relief CompletedThere is evidence that survivors of childhood cancer have a high prevalence of poor sleep, including symptoms of insomnia. Insomnia is highly comorbid and has been associated with impaired cognitive performance, a range of psychiatric disorders, cardiovascular disease, and reduce…
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New schizophrenia drug shows promise in large trial
Symptom relief CompletedThe purpose of this study was to evaluate the efficacy and safety of elpipodect at a range of doses (8 mg, 16 mg, and 24 mg once daily \[QD\]) in adult participants who have an acute episode of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders 5th E…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Better sleep, better mental health: new training approach tested in community clinics
Symptom relief CompletedThe train-the-trainer (TTT) approach is a promising method of sustaining training efforts in community mental health centers (CMHCs). This study will test the implementation and effectiveness outcomes of a sleep treatment delivered by CMHC providers who are trained and supervised…
Sponsor: University of California, Berkeley • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can a platelet booster keep chemo on track for lymphoma patients?
Disease control CompletedThe purpose of this study is to see if the study drug, romiplostim, helps low platelet count caused by standard chemotherapy treatment for lymphoma. This study will also look at whether romiplostim can prevent the need for chemotherapy dose delays, chemotherapy dose reductions, a…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Vaping prevention program put to the test in middle schools
Prevention CompletedThis is a two-arm, cluster randomized trial designed to to evaluate the effectiveness of an e-cigarette curriculum \[called the CATCH My Breath (CMB) program\] in delaying the onset of e-cigarette use in middle schoolers. Schools will be assigned to either the CMB program or usua…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 27, 2026 09:02 UTC
-
Can we ditch opioids after surgery? new trial aims to find out
Symptom relief Recruiting nowThe goal of this investigation is to compare effectiveness of this multimodal regimen at controlling postoperative pain with and without the use of opioid medications.
Phase 3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Blood test may predict implant scarring after breast cancer radiation
Diagnosis Recruiting nowThis study evaluates the capacity of the NovaGray RILA Breast® test to predict the toxicity linked to radiotherapy and the impact of implant breast reconstruction.
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Experimental drug aims to help COVID survivors breathe easier
Disease control Stopped earlyThis study is being conducted in two parts, A and B. Part A is a randomized, double-blind, parallel arm study to evaluate the safety and efficacy of LYT-100 compared to placebo in adults with post-acute COVID-19 respiratory complications. Part B is an Open Label Extension (OLE) s…
Phase 2 • Sponsor: PureTech • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug shows promise for shingles nerve pain
Symptom relief CompletedEvaluation of the efficacy of LX9211 compared to placebo in reducing pain related to postherpetic neuralgia over an 11 week assessment period.
Phase 2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New therapy helps autistic teens tame anger without medication
Symptom relief CompletedThis is a clinical trial of a novel intervention, Behavioral Therapy for Irritability and Aggression (BTIA), for adolescents on the autism spectrum. The main goals of BTIA are to help adolescents develop emotion regulation skills to handle frustration and to strengthen skills for…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could sex explain why sleep apnea harms women's hearts more?
Knowledge-focused CompletedPatients with sleep apnea are at increased risk of developing cardiovascular disease - with women at potentially greater risk than men. Contributing mechanisms are not well understood, but may be related to how women respond to low oxygen and, given over 70% of patients with slee…
Early phase 1 • Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Ketamine may cut opioid use after major aortic surgery
Symptom relief Recruiting nowThe objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).
Phase 2 • Sponsor: Sam Tyagi • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Immune cell test may predict kidney graft problems
Knowledge-focused OngoingDelayed/slow graft function is the most common complication after kidney transplantation with an incidence over 20% and is the result of ischemia-reperfusion injury. The increased use of marginal kidney grafts to palliate the organ shortage is leading to a continued rise in the i…
Sponsor: St. Louis University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC